A cutting-edge vaccine that can learn and adapt sounds like salvation, until success arrives faster than anyone is ready to reckon with.

As the COVID-19 pandemic ravages London in early 2020, Dr. Sofia Mendes, an infectious diseases specialist at St. Margaret's Hospital, is pushed to the limits of endurance. Working relentless shifts in overcrowded wards, she and her colleague Claire Thompson confront daily loss, equipment shortages, and the moral strain of rationing care.

When the city enters lockdown and the hospital begins to fracture, Sofia takes a risk. In secret, she and Claire convert a forgotten storage room into a makeshift lab, determined to revive Sofia's abandoned research project, Vitalis Redux, a radical decoy protein system designed to disrupt viral replication itself.

Outmatched and under-resourced, Sofia reaches out to her former research partner, Dr. Jolie Harding. Together, they attempt something unprecedented: an adaptive vaccine capable of evolving alongside the virus. Their work draws the attention of private investor Magnus Vale, whose funding brings speed and scale, but also control, scrutiny, and pressure that refuses to stay in the background.

As the research accelerates, Sofia's personal life begins to unravel. Her marriage strains under the weight of exhaustion and trauma, and when Claire succumbs to the virus, grief hardens into resolve. Sofia and Jolie push forward, driven by loss and urgency, racing to complete a vaccine that could change the course of the pandemic.

When their breakthrough succeeds, the world moves fast. Approval comes. Rollout follows. Media narratives take over. Scientific caution gives way to certainty, and the work that once belonged to a handful of exhausted researchers becomes a global instrument shaped by politics, markets, and public fear.

As the crisis fades and attention drifts elsewhere, Sofia is left to reckon with what remains, of the science, of the cost, and of herself.

Remnavax: The Discovery is the first novel in a grounded medical thriller trilogy set in the lived reality of the COVID era, exploring scientific ambition, institutional pressure, and the quiet aftermath of victory. It asks not how a cure is made, but what it demands, and what happens once the emergency ends.

Publisher: BookFuel

• We started tracking this book on January 5, 2026.
• The current price of this book is FREE last checked 8 minutes ago.
• This book is currently at its lowest price since we started tracking it.

• Text-to-Speech: Disabled
• Lending: Disabled
• Print Length: 334 Pages
• File Size: 19 KB